AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| TEM | TEM NZX Thread | 12/11/25 | 0 | 1 | |||
|
|||||||
| TEM | Ann: Net Asset Value as at 20 April 2018 | 24/04/18 | 0 | 8 | |||
|
|||||||
| TEM | Ann: Templeton Emerging Markets Investment Trust PLC ("TEMIT") | 24/04/18 | 0 | 7 | |||
|
|||||||
| TEM | Ann: Net Asset Value as at 19 April 2018 | 23/04/18 | 0 | 11 | |||
|
|||||||
| TEM | Ann: Templeton Emerging Markets Investment Trust PLC ("TEMIT") | 23/04/18 | 0 | 12 | |||
|
|||||||
| TEM | Ann: Net Asset Value as at 18 April 2018 | 20/04/18 | 0 | 19 | |||
|
|||||||
| TEM | Ann: Templeton Emerging Markets Investment Trust plc | 20/04/18 | 0 | 21 | |||
|
|||||||
| TEM | Ann: Net Asset Value as at 17 April 2018 | 19/04/18 | 0 | 12 | |||
|
|||||||
See All Discussions
flyingace
NZX News